Onkos Surgical partners with Integrum to expand US market for OPRA Implant System

Onkos Surgical entered a multi-year agreement with Integrum to expand the US market for Integrum's OPRA Implant System, an FDA-approved bone-anchored prosthetic technology for amputees.

“We are delighted to partner with Dr. Brånemark and Integrum, global experts and leading pioneers in the field of osseointegration.”prnewswire.com

• 1 source
• prnewswire.comOnkos Surgical® partners with Integrum® to expand US market for the OPRA™ Implant System; a revolutionary osseointegration and bone-anchored prosthetic technologyOnkos SurgicalJan 21, 2020

Summarized from public sources; check the original articles before acting on it.